Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)

NCT06042257 is registered in ClinicalTrials.gov with Rachel G. Greenberg, MD, MB, MHS as lead sponsor.

NCT NCT06042257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06042257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)
Lead sponsor
Rachel G. Greenberg, MD, MB, MHS
Phase
Phase 2
Overall status
Terminated
Start date
December 9, 2024
Completion date
August 12, 2025
Enrollment
3 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

hyperactivity in children with down syndrome, impulsivity in children with down syndrome